Matthew Seigerman (@mseigsmd) 's Twitter Profile
Matthew Seigerman

@mseigsmd

Interventional Cardiologist @ Cardiac Specialists (@ynhhealth @bpthosp) • Alumni @PennCardiology @IcahnMountSinai @Wharton

ID: 967044251900170241

linkhttps://cardiacspecialists.com calendar_today23-02-2018 14:31:31

178 Tweet

477 Takipçi

382 Takip Edilen

Yael L. Maxwell (@tctmd_yael) 's Twitter Profile Photo

For the next 5-10 years, ⁦ron waksman⁩ predicts TEER will dominate over TMVR, but agrees with ⁦Michael Reardon⁩ that we’ve hit an “inflection point” with TMVR in the last 6 months #CRT2023

For the next 5-10 years, ⁦<a href="/ronwaksman/">ron waksman</a>⁩ predicts TEER will dominate over TMVR, but agrees with ⁦<a href="/MReardon19/">Michael Reardon</a>⁩ that we’ve hit an “inflection point” with TMVR in the last 6 months #CRT2023
Amir Kaki, MD (@dramirkaki) 's Twitter Profile Photo

Congratulations to Jay Giri and the co investigators. This is a giant leap forward for the field of high risk PE. Very compelling, time to update the guidelines??!!

Jay Giri (@jaygirimd) 's Twitter Profile Photo

Looking forward to addressing arguably the most important scientific question in acute PE care with this landmark trial that will evaluate meaningful clinical endpoints. Excited to recruit centers in both the US and EU for this endeavor!

RTHahnMD (@hahn_rt) 's Twitter Profile Photo

Great review of current literature on peridevice leak post-LAAO. ⬆️Ischemic events, ­⬆️bleeding. Modifiable factors including undersizing, coaxiality of device to LAA! bit.ly/LAAO_PDL Mohamad Alkhouli DJ Lakkireddy Jacqueline Saw JACC Journals American College of Cardiology Omar Khalique

MyJSCAI (@myjscai) 's Twitter Profile Photo

📢. SCAI Position Statement on Renal Denervation for Hypertension - review of pt selection, training, & procedural considerations #RDN #HTN 🆕💡 ➡️doi.org/10.1016/j.jsca…

📢. <a href="/SCAI/">SCAI</a> Position Statement on Renal Denervation for Hypertension - review of pt selection,  training, &amp; procedural considerations  #RDN #HTN  🆕💡

➡️doi.org/10.1016/j.jsca…
Jay Giri (@jaygirimd) 's Twitter Profile Photo

PEERLESS II aims to randomize 1200 patients at 100 international sites in order to address arguably the most important issue in current inpatient PE management: the impact of thrombectomy on meaningful clinical endpoints. Thanks to all of the participating sites!

Tai Kobayashi (@taikobayashimd) 's Twitter Profile Photo

For those interested in RDN, please consider joining our Penn Invasive Symposium. It will be the first in the nation to show cases from both FDA approved devices as well as hands on simulators on site for new operators! ⁦Register here: upenn.cloud-cme.com/course/courseo…

Andrew M. Goldsweig, MD, MS (@agoldsweig) 's Twitter Profile Photo

🌶️Hot in Circ: CQO:🌶️ 🔥#PFO closure increased 39% from 2006-19. 🔥41% of PFO closures were for off-label (non-stroke) indications! 🔥#Afib rate was 18% baseline + 12% new post-procedure. pubmed.ncbi.nlm.nih.gov/38189127/ Terrific coverage by Yael L. Maxwell: tctmd.com/news/many-pfo-…

🌶️Hot in <a href="/CircOutcomes/">Circ: CQO</a>:🌶️

🔥#PFO closure increased 39% from 2006-19.

🔥41% of PFO closures were for off-label (non-stroke) indications!

🔥#Afib rate was 18% baseline + 12% new post-procedure.

pubmed.ncbi.nlm.nih.gov/38189127/

Terrific coverage by <a href="/TCTMD_Yael/">Yael L. Maxwell</a>: tctmd.com/news/many-pfo-…
C. Michael Gibson MD (@cmichaelgibson) 's Twitter Profile Photo

A single combined measure of hsCRP, LDL-C, and Lp(a) among initially healthy women was predictive of incident cardiovascular events over a 30-year period. All 3 biomarkers are modifiable thru either lifestyle or pharmacologic interventions #ESCCongress #cardiology #prevention

A single combined measure of hsCRP, LDL-C, and Lp(a) among initially
healthy women was predictive of incident cardiovascular events
over a 30-year period. All 3 biomarkers are modifiable thru either lifestyle or pharmacologic interventions #ESCCongress #cardiology #prevention
Jay Giri (@jaygirimd) 's Twitter Profile Photo

Landmark PERSEVERE trial announced European Society of Cardiology 2024 RCT for high risk massive PE: large bore thrombectomy vs standard of care. Mortality 20-30% with standard of care 1 past RCT in this group with only 8 patients. The “Golden Era of PE RCT” continues! sciencedirect.com/science/articl…